Opendata, web and dolomites
MERCK SHARP & DOHME CORP (United States of America): list of projects
The following table shows the list of Horizon 2020 projects developed by "MERCK SHARP & DOHME CORP". Projects are ordered by starting date.
Click on table headers to rearrange data.
| # | acronym | programme | role | EC contrib. | start | views |
|---|---|---|---|---|---|---|
| 1 | ADAPT-SMART | H2020-EU.3.1.7.13. | participant | 0.00 | 2015-07-01 | 663 |
| 2 | PREFER | H2020-EU.3.1.7. | participant | 0.00 | 2016-10-01 | 616 |
| 3 | DO-IT | H2020-EU.3.1.7. | participant | 0.00 | 2017-02-01 | 983 |
| 4 | IB4SD-TRISTAN | H2020-EU.3.1.7. | participant | 0.00 | 2017-01-01 | 905 |
| 5 | VSV-EBOPLUS | H2020-EU.3.1.7. | participant | 0.00 | 2016-04-01 | 818 |
| 6 | PARADIGM | H2020-EU.3.1.7. | participant | 0.00 | 2018-03-01 | 553 |
| 7 | VITAL | H2020-EU.3.1.7. | participant | 0.00 | 2019-01-01 | 249 |
| 8 | NeuroDeRisk | H2020-EU.3.1.7. | participant | 0.00 | 2019-03-01 | 275 |
| 9 | TransBioLine | H2020-EU.3.1.7. | participant | 0.00 | 2019-02-01 | 254 |
| 10 | PharmaLedger | H2020-EU.3.1.7. | participant | 0.00 | 2020-01-01 | 361 |
| totale | 0.00 | |||||
Network analysis
This organization collaborated with partners in 25 countries.
ADAPT-SMART
Within the project ADAPT-SMART this organization got in touch with:
| role | cy | shortname | name |
|---|---|---|---|
| participant | CH | SHIRE | SHIRE INTERNATIONAL GMBH (PRC) |
| participant | UK | AbbVie | AbbVie Ltd (PRC) |
| participant | BE | UCB | UCB BIOPHARMA SRL (PRC) |
| participant | IT | AIFA | AGENZIA ITALIANA DEL FARMACO (PRC) |
| participant | FR | Lysogene | LYSOGENE (PRC) |
| participant | BE | EFPIA | FEDERATION EUROPEENNE D'ASSOCIATIONS ET D'INDUSTRIES PHARMACEUTIQUES (OTH) |
| participant | UK | Astellas | ASTELLAS PHARMA EUROPE LTD (PRC) |
| participant | NL | ZIN | ZORGINSTITUUT NEDERLAND (PUB) |
| participant | FR | IPSEN | IPSEN INNOVATION SAS (PRC) |
| participant | FR | HAS | HAUTE AUTORITE DE SANTE (PUB) |
| participant | FR | EURORDIS | EURORDIS - EUROPEAN ORGANISATION FOR RARE DISEASES ASSOCIATION (OTH) |
| participant | UK | NICE | NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (PUB) |
| participant | US | BMS | BRISTOL-MYERS SQUIBB COMPANY CORP (PRC) |
| participant | BE | Amgen | AMGEN (PRC) |
| participant | UK | Eli Lilly | Eli Lilly and Company Limited (PRC) |
| participant | UK | EMA | THE EUROPEAN MEDICINES AGENCY (PUB) |
| coordinator | NL | LYGATURE | STICHTING LYGATURE (OTH) |
| participant | FR | IRIS | INSTITUT DE RECHERCHES INTERNATIONALES SERVIER (PRC) |
| participant | DE | Bayer | Bayer Pharma AG (PRC) |
| participant | US | MIT | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (HES) |
| participant | UK | PFIZER | PFIZER LIMITED (PRC) |
| participant | FR | SARD | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
| participant | DE | BI | BOEHRINGER INGELHEIM INTERNATIONALGMBH (PRC) |
| participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
| participant | DK | DHMA | SUNDHEDSSTYRELSEN (PUB) |
| participant | LU | EPF | FORUM EUROPEEN DES PATIENTS (FPE) (OTH) |
| participant | CH | ROCHE | F. HOFFMANN-LA ROCHE AG (PRC) |
| participant | CH | NOVARTIS | NOVARTIS PHARMA AG (PRC) |
| participant | DK | Lundbeck | H. LUNDBECK AS (PRC) |
| participant | UK | GSK | GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. (PRC) |
| participant | DK | Novo Nordisk | NOVO NORDISK A/S (PRC) |
| participant | SE | MEDIMMUNE | ASTRAZENECA AB (PRC) |
| participant | DE | Merck | MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN (PRC) |
| participant | UK | UOXF | THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD (HES) |
PREFER
Within the project PREFER this organization got in touch with:
| role | cy | shortname | name |
|---|---|---|---|
| participant | DE | SPM | STEINBEISSER PROJECT MANAGEMENT UG (HAFTUNGSBESCHRANKT) (PRC) |
| participant | DE | CSL | CSL BEHRING GMBH (PRC) |
| participant | UK | MDUK | MUSCULAR DYSTROPHY GROUP OF GREAT BRITAIN AND NORTHERN IRELAND (OTH) |
| participant | BE | MB | MINDBYTES (PRC) |
| participant | UK | AbbVie | AbbVie Ltd (PRC) |
| participant | UK | IAPO | INTERNATIONAL ALLIANCE OF PATIENT'ORGANIZATIONS (OTH) |
| participant | UK | Amgen | AMGEN LIMITED (PRC) |
| participant | BE | KCE | FEDERAAL KENNISCENTRUM VOOR DE GEZONDHEIDSZORG (REC) |
| participant | UK | Takeda | TAKEDA DEVELOPMENT CENTRE EUROPE LTD (PRC) |
| participant | BE | ECPC | EUROPEAN CANCER PATIENT COALITION (OTH) |
| participant | IT | ITB | "INSTITUTO TUMORI ""GIOVANNI PAOLO II""" (REC) |
| participant | NL | ASTELLAS | ASTELLAS PHARMA EUROPE BV (PRC) |
| participant | UK | Lilly | Eli Lilly and Company Limited (PRC) |
| participant | DE | Bayer | Bayer Pharma AG (PRC) |
| participant | UK | Pfizer | PFIZER LIMITED (PRC) |
| participant | FR | SANOFI | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
| participant | BE | JP | JANSSEN PHARMACEUTICA NV (PRC) |
| participant | LU | EPF | FORUM EUROPEEN DES PATIENTS (FPE) (OTH) |
| participant | CH | ROCHE | F. HOFFMANN-LA ROCHE AG (PRC) |
| participant | CH | NVS | NOVARTIS PHARMA AG (PRC) |
| participant | CH | Actelion | ACTELION PHARMACEUTICALS LTD (PRC) |
| participant | NL | ERASMUS | ERASMUS UNIVERSITEIT ROTTERDAM (HES) |
| participant | DE | UKER | UNIVERSITATSKLINIKUM ERLANGEN (HES) |
| participant | UK | UoB | THE UNIVERSITY OF BIRMINGHAM (HES) |
| participant | NL | UMCU | UNIVERSITAIR MEDISCH CENTRUM UTRECHT (HES) |
| participant | SE | MEDIMMUNE | ASTRAZENECA AB (PRC) |
| participant | DE | Merck | MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN (PRC) |
| participant | IT | IEO | ISTITUTO EUROPEO DI ONCOLOGIA SRL (PRC) |
| coordinator | SE | UU | UPPSALA UNIVERSITET (HES) |
| participant | UK | UNEW | UNIVERSITY OF NEWCASTLE UPON TYNE (HES) |
| participant | NL | EMC | ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM (HES) |
| participant | BE | KUL | KATHOLIEKE UNIVERSITEIT LEUVEN (HES) |
DO-IT
Within the project DO-IT this organization got in touch with:
| role | cy | shortname | name |
|---|---|---|---|
| participant | UK | HIQ | HEALTH IQ LIMITED (PRC) |
| participant | UK | ABPI | THE ASSOCIATION OF THE BRITISH PHARMACEUTICAL INDUSTRY (OTH) |
| participant | DE | Bayer | BAYER AKTIENGESELLSCHAFT (PRC) |
| participant | SE | IHE | IHE, INSTITUTET FOR HALSO- OCH SJUKVARDSEKONOMI AKTIEBOLAG (PRC) |
| participant | NO | NoMA | STATENS LEGEMIDDELVERK (PUB) |
| participant | CH | Celgene | CELGENE MANAGEMENT SARL (PRC) |
| participant | BE | UCB | UCB BIOPHARMA SRL (PRC) |
| participant | BE | EFPIA | FEDERATION EUROPEENNE D'ASSOCIATIONS ET D'INDUSTRIES PHARMACEUTIQUES (OTH) |
| participant | SE | TLV | TANDVARDS-OCH LAKEMEDELSFORMANSVERKET (PUB) |
| participant | ES | FI | ASOCIACION NACIONAL EMPRESARIAL DE LA INDUSTRIA FARMACEUTICA (OTH) |
| participant | DE | VFA | VERBAND FORSCHENDER ARZNEIMITTELHERSTELLER EV (OTH) |
| participant | BE | EMSP | THE EUROPEAN MULTIPLE SCLEROSIS PLATFORM AISBL (OTH) |
| participant | BE | ECPC | EUROPEAN CANCER PATIENT COALITION (OTH) |
| participant | DE | TMF | TMF - TECHNOLOGIE UND METHODENPLATTFORM FUR DIE VERNETZTE MEDIZINISCHE FORSCHUNG EV (REC) |
| participant | UK | NICE | NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (PUB) |
| participant | BE | Amgen | AMGEN (PRC) |
| participant | UK | ELI LILLY | Eli Lilly and Company Limited (PRC) |
| participant | FR | IRIS | INSTITUT DE RECHERCHES INTERNATIONALES SERVIER (PRC) |
| participant | DE | InterSystems | INTERSYSTEMS GMBH (PRC) |
| participant | UK | Pfizer | PFIZER LIMITED (PRC) |
| participant | FR | SARD | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
| participant | DE | BI | BOEHRINGER INGELHEIM INTERNATIONALGMBH (PRC) |
| participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
| participant | NO | NIPH | FOLKEHELSEINSTITUTTET (REC) |
| participant | CH | ROCHE | F. HOFFMANN-LA ROCHE AG (PRC) |
| participant | CH | NOV | NOVARTIS PHARMA AG (PRC) |
| participant | IT | CERGAS | UNIVERSITA COMMERCIALE LUIGI BOCCONI (HES) |
| participant | HU | SU | SEMMELWEIS EGYETEM (HES) |
| coordinator | UK | LSE | LONDON SCHOOL OF ECONOMICS AND POLITICAL SCIENCE (HES) |
| participant | UK | GSK | GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. (PRC) |
| participant | DK | Novo | NOVO NORDISK A/S (PRC) |
| participant | DE | Merck | MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN (PRC) |
| participant | UK | ULIV | THE UNIVERSITY OF LIVERPOOL (HES) |
| participant | UK | Imperial | IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE (HES) |
| participant | FR | INSERM | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (REC) |
IB4SD-TRISTAN
Within the project IB4SD-TRISTAN this organization got in touch with:
| role | cy | shortname | name |
|---|---|---|---|
| participant | SE | Antaros | ANTAROS MEDICAL AB (PRC) |
| participant | SE | TRULY | TRULY LABS AB (PRC) |
| participant | DE | Bruker | BRUKER BIOSPIN MRI GMBH (PRC) |
| participant | UK | Bioxydyn | BIOXYDYN LIMITED (PRC) |
| participant | DE | AbbVie | ABBVIE DEUTSCHLAND GMBH & CO KG (PRC) |
| participant | DE | Sanofi | SANOFI-AVENTIS DEUTSCHLAND GMBH (PRC) |
| participant | DE | Bayer | Bayer Pharma AG (PRC) |
| participant | UK | Pfizer | PFIZER LIMITED (PRC) |
| coordinator | BE | EORTC | EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL (REC) |
| participant | UK | GE | GE HEALTHCARE LIMITED (PRC) |
| participant | FR | UB | UNIVERSITE DIJON BOURGOGNE (HES) |
| participant | SE | ULUND | LUNDS UNIVERSITET (HES) |
| participant | UK | UNIMAN | THE UNIVERSITY OF MANCHESTER (HES) |
| participant | NL | UMCG | ACADEMISCH ZIEKENHUIS GRONINGEN (HES) |
| participant | UK | GSK | GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. (PRC) |
| participant | DK | Novo Nordisk | NOVO NORDISK A/S (PRC) |
| participant | UK | ULEEDS | UNIVERSITY OF LEEDS (HES) |
| participant | UK | UOS | THE UNIVERSITY OF SHEFFIELD (HES) |
| participant | SE | CHALMERS | CHALMERS TEKNISKA HOEGSKOLA AB (HES) |
| participant | NL | RUMC | STICHTING KATHOLIEKE UNIVERSITEIT (HES) |
VSV-EBOPLUS
Within the project VSV-EBOPLUS this organization got in touch with:
| role | cy | shortname | name |
|---|---|---|---|
| coordinator | IT | SVA | SCLAVO VACCINES ASSOCIATION (REC) |
| participant | CH | VBS-LS | EIDGENOSSISCHES DEPARTEMENT FUR VERTEIDIGUNG, BEVOLKERUNGSSCHUTZ UND SPORT (PUB) |
| participant | GA | CERMEL | Centre de Recherches Medicales de Lambaréné (REC) |
| participant | IT | Microbiotec | MICROBIOTEC SRL (PRC) |
| participant | BR | USP | UNIVERSIDADE DE SAO PAULO (HES) |
| participant | IT | UNISI | UNIVERSITA DEGLI STUDI DI SIENA (HES) |
| participant | CH | UNIGE | UNIVERSITE DE GENEVE (HES) |
| participant | SE | UGOT | GOETEBORGS UNIVERSITET (HES) |
| participant | NL | LUMC | ACADEMISCH ZIEKENHUIS LEIDEN (HES) |
| participant | DE | EKUT | EBERHARD KARLS UNIVERSITAET TUEBINGEN (HES) |
PARADIGM
Within the project PARADIGM this organization got in touch with:
| role | cy | shortname | name |
|---|---|---|---|
| participant | BE | Alexion | ALEXION SERVICES EUROPE SPRL (PRC) |
| participant | CA | HTAi | HEALTH TECHNOLOGY ASSESSMENT INTERNATIONAL SOCIETY (OTH) |
| participant | BE | Synergist | THE SYNERGIST (OTH) |
| participant | UK | ABPI | THE ASSOCIATION OF THE BRITISH PHARMACEUTICAL INDUSTRY (OTH) |
| participant | DE | Bayer AG | BAYER AKTIENGESELLSCHAFT (PRC) |
| participant | BE | UCB | UCB BIOPHARMA SRL (PRC) |
| participant | IT | AIFA | AGENZIA ITALIANA DEL FARMACO (PRC) |
| participant | UK | Amgen | AMGEN LIMITED (PRC) |
| participant | BE | EFPIA | FEDERATION EUROPEENNE D'ASSOCIATIONS ET D'INDUSTRIES PHARMACEUTIQUES (OTH) |
| participant | NL | STICHTING VU | STICHTING VU (HES) |
| participant | DE | VFA | VERBAND FORSCHENDER ARZNEIMITTELHERSTELLER EV (OTH) |
| participant | FR | EURORDIS | EURORDIS - EUROPEAN ORGANISATION FOR RARE DISEASES ASSOCIATION (OTH) |
| participant | DE | GRT | GRUNENTHAL GMBH (PRC) |
| participant | UK | Covance | COVANCE LABORATORIES LTD (PRC) |
| participant | ES | SYNAPSE | SYNAPSE RESEARCH MANAGEMENT PARTNERS SL (PRC) |
| participant | UK | Eli Lilly | Eli Lilly and Company Limited (PRC) |
| participant | FR | IRIS | INSTITUT DE RECHERCHES INTERNATIONALES SERVIER (PRC) |
| participant | LU | AE | ALZHEIMER EUROPE (OTH) |
| participant | UK | PFIZER | PFIZER LIMITED (PRC) |
| participant | FR | SARD | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
| participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
| participant | ES | IACS | INSTITUTO ARAGONES DE CIENCIAS DE LA SALUD (REC) |
| participant | DE | EATG | EUROPEAN AIDS TREATMENT GROUP EV (OTH) |
| coordinator | LU | EPF | FORUM EUROPEEN DES PATIENTS (FPE) (OTH) |
| participant | ES | FSJD | FUNDACIO SANT JOAN DE DEU (REC) |
| participant | CH | ROCHE | F. HOFFMANN-LA ROCHE AG (PRC) |
| participant | CH | NOVARTIS | NOVARTIS PHARMA AG (PRC) |
| participant | DK | Lundbeck | H. LUNDBECK AS (PRC) |
| participant | UK | GSK | GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. (PRC) |
| participant | DK | Novo Nordisk | NOVO NORDISK A/S (PRC) |
| participant | BE | EFGCP | EUROPEAN FORUM FOR GOOD CLINICAL PRACTICE (OTH) |
| participant | DE | Merck | MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN (PRC) |
| participant | UK | UOXF | THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD (HES) |
VITAL
Within the project VITAL this organization got in touch with:
| role | cy | shortname | name |
|---|---|---|---|
| participant | RS | MiHA | MIHAJLOVIC JOVAN (PRC) |
| participant | ES | FISABIO | FUNDACION PARA EL FOMENTO DE LA INVESTIGACION SANITARIA Y BIOMEDICA DE LA COMUNITAT VALENCIANA (REC) |
| participant | BE | EFPIA | FEDERATION EUROPEENNE D'ASSOCIATIONS ET D'INDUSTRIES PHARMACEUTIQUES (OTH) |
| participant | HU | SYREON | SYREON KUTATO INTEZET KORLATOLT FELELOSSEGU TARSASAG (PRC) |
| participant | BE | P95 | P95 CVBA (PRC) |
| participant | NL | JAN | JANSSEN VACCINES & PREVENTION BV (PRC) |
| participant | FR | bMx | BIOMERIEUX SA (PRC) |
| participant | BE | GSK Bio | GLAXOSMITHKLINE BIOLOGICALS SA (PRC) |
| participant | UK | PFIZER | PFIZER LIMITED (PRC) |
| participant | NO | NIPH | FOLKEHELSEINSTITUTTET (REC) |
| participant | IT | UNIFE | UNIVERSITA DEGLI STUDI DI FERRARA (HES) |
| participant | AT | ACINN | UNIVERSITAET INNSBRUCK (HES) |
| participant | FR | UJM | UNIVERSITE JEAN MONNET SAINT-ETIENNE (HES) |
| participant | NL | UMCG | ACADEMISCH ZIEKENHUIS GRONINGEN (HES) |
| coordinator | NL | UMCU | UNIVERSITAIR MEDISCH CENTRUM UTRECHT (HES) |
| participant | DK | SSI | STATENS SERUM INSTITUT (REC) |
| participant | FR | SP | SANOFI PASTEUR SA (PRC) |
| participant | UK | UCL | UNIVERSITY COLLEGE LONDON (HES) |
| participant | IT | ISS | ISTITUTO SUPERIORE DI SANITA (REC) |
| participant | NL | RIVM | RIJKSINSTITUUT VOOR VOLKSGEZONDHEID EN MILIEU (REC) |
| participant | UK | Imperial | IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE (HES) |
| participant | FR | INSERM | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (REC) |
| participant | FR | CNRS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS (REC) |
NeuroDeRisk
Within the project NeuroDeRisk this organization got in touch with:
| role | cy | shortname | name |
|---|---|---|---|
| participant | US | FCDI | FUJIFILM CELLULAR DYNAMICS INC (PRC) |
| participant | FR | UCA | UNIVERSITE CLERMONT AUVERGNE (HES) |
| participant | RS | UNIBEO | FARMACEUTSKI FAKULTET UNIVERZITETAU BEOGRADU (HES) |
| participant | BE | UCB | UCB BIOPHARMA SRL (PRC) |
| participant | FR | ALCEDIAG | ALCEDIAG (PRC) |
| participant | EL | BIOVISTA | A. PERSIDIS & SIA OE (PRC) |
| participant | FI | UEF | ITA-SUOMEN YLIOPISTO (HES) |
| participant | UK | PFIZER | PFIZER LIMITED (PRC) |
| participant | FR | SARD | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
| participant | PT | ICETA | ICETA INSTITUTO DE CIENCIAS, TECNOLOGIAS E AGROAMBIENTE DA UNIVERSIDADE DO PORTO (REC) |
| participant | AT | IL | INTE:LIGAND SOFTWARE-ENTWICKLUNGS-UND CONSULTING GMBH (PRC) |
| participant | CH | NOVARTIS | NOVARTIS PHARMA AG (PRC) |
| coordinator | AT | UW-APRI | UNIVERSITAT WIEN (HES) |
| participant | IT | CRIACIV LABIMA | UNIVERSITA DEGLI STUDI DI FIRENZE (HES) |
| participant | SE | MEDIMMUNE | ASTRAZENECA AB (PRC) |
| participant | SE | UU | UPPSALA UNIVERSITET (HES) |
| participant | AT | MUW | MEDIZINISCHE UNIVERSITAET WIEN (HES) |
TransBioLine
Within the project TransBioLine this organization got in touch with:
| role | cy | shortname | name |
|---|---|---|---|
| participant | DE | Signatope | SIGNATOPE GMBH (PRC) |
| participant | LU | ITTM | INFORMATION TECHNOLOGY FOR TRANSLATIONAL MEDICINE (ITTM) SA (PRC) |
| participant | DE | METAHEPS | METAHEPS GMBH (PRC) |
| participant | AT | TAM | TAMIRNA GMBH (PRC) |
| participant | DE | MLM | MLM MEDICAL LABS GMBH (PRC) |
| participant | DE | ABX CRO | ABX CRO ADVANCED PHARMACEUTICAL SERVICES FORSCHUNGSGESELLSCHAFT MBH (PRC) |
| participant | ES | SYNAPSE | SYNAPSE RESEARCH MANAGEMENT PARTNERS SL (PRC) |
| participant | UK | Lilly | Eli Lilly and Company Limited (PRC) |
| participant | UK | Pfizer | PFIZER LIMITED (PRC) |
| participant | FR | SARD | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
| participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
| participant | ES | SAS | SERVICIO ANDALUZ DE SALUD (PUB) |
| participant | ES | IR-HSCSP | FUNDACIO PRIVADA INSTITUT DE RECERCA DE L'HOSPITAL DE LA SANTA CREU I SANT PAU (REC) |
| participant | CH | ROCHE | F. HOFFMANN-LA ROCHE AG (PRC) |
| participant | FR | AP-HP | ASSISTANCE PUBLIQUE HOPITAUX DE PARIS (REC) |
| participant | CH | NOVARTIS | NOVARTIS PHARMA AG (PRC) |
| participant | IS | LANDSPITALI | LANDSPITALI UNIVERSITY HOSPITAL (HES) |
| participant | ES | USAL | UNIVERSIDAD DE SALAMANCA (HES) |
| participant | ES | UMA | UNIVERSIDAD DE MALAGA (HES) |
| participant | NL | ULEI | UNIVERSITEIT LEIDEN (HES) |
| coordinator | CH | UZH | UNIVERSITAT ZURICH (HES) |
| participant | UK | UNOT | THE UNIVERSITY OF NOTTINGHAM (HES) |
| participant | DE | LMU MUENCHEN | LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN (HES) |
| participant | UK | ULIV | THE UNIVERSITY OF LIVERPOOL (HES) |
| participant | UK | UNEW | UNIVERSITY OF NEWCASTLE UPON TYNE (HES) |
| participant | DE | Charite | CHARITE - UNIVERSITAETSMEDIZIN BERLIN (HES) |
PharmaLedger
Within the project PharmaLedger this organization got in touch with:
| role | cy | shortname | name |
|---|---|---|---|
| participant | PT | HES | HOSPITAL DO ESPIRITO SANTO DE EVORA EPE (PUB) |
| participant | PT | INCM | IMPRENSA NACIONAL - CASA DA MOEDA, S. A. (PRC) |
| participant | DE | BAYER | BAYER AKTIENGESELLSCHAFT (PRC) |
| participant | BE | UCB | UCB BIOPHARMA SRL (PRC) |
| participant | IL | AVO | ARTEEVO TECHNOLOGIES LTD (PRC) |
| participant | US | ABBV | ABBVIE INC (PRC) |
| participant | UK | TVS | TECHNOVATIVE SOLUTIONS LTD (PRC) |
| participant | UK | ONO | ONORACH LTD (PRC) |
| participant | DE | UKW | UNIVERSITAETSKLINIKUM WUERZBURG - KLINIKUM DER BAYERISCHEN JULIUS-MAXIMILIANS-UNIVERSITAT (HES) |
| participant | UK | PFE | PFIZER LIMITED (PRC) |
| participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
| participant | EL | CERTH | ETHNIKO KENTRO EREVNAS KAI TECHNOLOGIKIS ANAPTYXIS (REC) |
| participant | IL | EKN | EKON MODELING SOFWARE SYSTEMS LTD*EKON (PRC) |
| participant | IT | OPB | OSPEDALE PEDIATRICO BAMBINO GESU (OTH) |
| participant | LU | EPF | FORUM EUROPEEN DES PATIENTS (FPE) (OTH) |
| participant | RO | INCDTCI ICSI | NATIONAL RESEARCH AND DEVELOPMENT INSTITUTE FOR CRYOGENICS AND ISOTOPIC TECHNOLOGIES ICSI RM VALCEA (REC) |
| participant | CH | ROCHE | F. HOFFMANN-LA ROCHE AG (PRC) |
| participant | EL | DUT | DIMOKRITIO PANEPISTIMIO THRAKIS (HES) |
| participant | PT | PDM | PDM E FC PROJECTO DESENVOLVIMENTO MANUTENCAO FORMACAO E CONSULTADORIALDA (PRC) |
| participant | CH | NVS | NOVARTIS PHARMA AG (PRC) |
| participant | RO | RMS | ROMSOFT SRL (PRC) |
| participant | UK | GSK | GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. (PRC) |
| participant | DK | NOVO | NOVO NORDISK A/S (PRC) |
| participant | SE | AZN | ASTRAZENECA AB (PRC) |
| participant | BE | EFGCP | EUROPEAN FORUM FOR GOOD CLINICAL PRACTICE (OTH) |
| coordinator | ES | UPM | UNIVERSIDAD POLITECNICA DE MADRID (HES) |
| participant | BE | KU Leuven | KATHOLIEKE UNIVERSITEIT LEUVEN (HES) |